In 2023, nearly ** percent of the population of the United States used cannabis within the past year. The graph shows the percentage of the population in the U.S. who consumed cannabis in the past year from 2002 to 2023.

In 2023, approximately 61.8 million people used marijuana in the past year. This statistic shows the number of people in the U.S. who have used marijuana in the past year from 2009 to 2023.

Current marijuana use among U.S. adults in 2022 was highest in Vermont, where around 34.37 percent of adults reported using marijuana within the past year. In recent years, a number of U.S. states, including Colorado and California, have legalized the sale of marijuana for recreational use. In 2022, around 132 million people in the United States reported that they had used marijuana at least once in their lifetime.

Consumer behavior Starting around 2013, the majority of U.S. adults now say they are in favor of legalizing marijuana in the United States. The share of adults who were in favor of legalization has continued to increase over the years. As of 2021, about 68 percent of U.S. adults aged 18 and older were in favor of legalization. Legal sales of marijuana reached 16.5 billion U.S. dollars in 2021, and are expected to increase to around 37 billion dollars by the year 2026.

COVID-19 impact on marijuana use The COVID-19 pandemic and resulting lockdowns led to fears of an increase in substance abuse in many parts of the world. In March 2020, around 40 percent of millennials who used cannabis in the past year reported that they planned to increase their marijuana use during the COVID-19 pandemic. This rise in usage was reflected in sales early in the pandemic. In California for example, sales of marijuana on March 16, 2020 increased 159 percent compared to the same day in 2019.

As of fall 2024, around ***percent of U.S. college students who had ever used cannabis had used it daily or almost daily in the past 3 months. This statistic presents the percentage of college students in the U.S. that had used marijuana during the past 3 months as of fall 2024, by frequency. Substance use among college students In 2024, alcohol was the most widely used substance among U.S. college students, followed by cannabis and tobacco products. At that time, around ** percent of college students reported they had drank alcohol at some point in their lifetime. Furthermore, nearly ********* of students reported using marijuana within the past thirty days. Unfortunately, substance use is often a maladaptive coping strategy used to deal with academic and social pressures, difficult emotions, and stress. Substance use and mental health Using substances can exacerbate existing mental health difficulties, as substance use and mental disorders often go-hand in hand. This is an issue of utmost importance due to the higher risk of suicide and self-harm behaviors among the college-aged population in the United States. Although over *********** of college students receiving mental health services also felt the need to reduce their drug and alcohol use in 2024, only *** percent reported actually receiving treatment for drug or alcohol use alongside their mental health treatment.

The District of Columbia holds the record for the highest price per ounce of high quality marijuana in the United States, as of January 2025, with an average price of some 590 U.S. dollars per ounce. Recreational cannabis use Recreational cannabis is not legal in all U.S. states; however, many consumers use the drug illicitly. A recent survey indicated that over half of U.S. adults think that cannabis should be legalized and taxed like alcohol and tobacco. Recreational cannabis is often used by consumers for relaxation, stress relief, and creativity, to name a few. Surveys have shown that a majority of recreation users use marijuana for relaxation. Legal marijuana market potential It is projected that by 2025 the sales of legal cannabis in the U.S. will generate approximately 25 billion dollars in revenue. The regulation of marijuana includes the taxation of all sales. There is potential for the U.S. cannabis market to generate significant taxes and boost the economy. It is estimated that the taxes from legal marijuana sales would exceed the taxes earned from U.S. sales taxes by a significant amount.

Eighteen to twenty-nine-year-olds were the largest group of current marijuana smokers in the United States in 2019. Roughly a quarter of the age group were current smokers, with usage dipping among older age groups. Seniors were the least likely, with only three percent stating that they were current smokers.

Support for legalization

Although cannabis is still federally illegal, it has been legalized for recreational consumption in 10 states since 2012. Nationwide support for the federal legalization of cannabis has grown every year, with 18 to 34-year-olds being the biggest supporters. Seventy-eight-percent of Americans in that age group supported marijuana legalization in 2018, nearly double the level of support in 2003. Approval of legalization is more than 50 percent among all age groups.

Approval for medical use

Support for the medical usage of cannabis is even higher, and unlike recreational usage, approval levels are very close among all age groups. The average degree of support among all age groups was seventy-four percent. In contrast to the young age of most recreational smokers, in Oregon, one of the first state to legalize recreational cannabis, the highest share of people registered as medical marijuana patients were 55 to 69 years old.

A 2021 survey of American high school students found that around 27.8 percent of students had used marijuana at at least one instance in their lifetime. The prevalence of marijuana use was higher among female students.

This graph shows a comparison between the adult market penetration rate of legal cannabis, including both recreational and medical marijuana, and other common stimulants and substances. Cannabis is expected to have a market penetration rate of 20 percent, compared to 50 percent for alcohol and 40 percent for painkillers.

This statistic shows the prevalence of cannabis use among Americans as of 2019, by generation. In 2019, ** percent of Gen Z respondents stated that they either occasionally or regularly used cannabis.

This graph shows the number of legal medical marijuana patients by U.S. state, per 1,000 state residents, as of May 17, 2018. The state of Colorado had the highest rate of legal medical marijuana patients per 1,000 state residents with 15.86 patients.

This graph shows the percentage of U.S. respondents in selected opinion polls between 1995 and 2015 who were in favor of medical marijuana. Throughout the period those in favor of medical marijuana never dropped below ** percent, and a poll from Fox News in May 2013 found that a high of ** percent of respondents were in favor.

The spot price for wholesale cannabis in the United States has fluctuated over the past three years. In January 2024, the spot price of wholesale cannabis was ***** U.S. dollars per pound.

The spot price for wholesale indoor cannabis in the United States rose from 2019 to 2021 before declining in 2022 and again in 2023. The price of indoor cannabis stood at ***** U.S. dollars per pound in January 2023.

In 2023, it was estimated that around *** million people in the United States had used ecstasy, also known as MDMA or Molly, in the past year. MDMA is a synthetic drug that produces feelings of pleasure and emotional warmth, as well as increased empathy, energy, and sense of well-being. MDMA may also cause negative effects such as nausea, jaw clenching, chills, and disorganized thoughts, but deaths from MDMA overdose are rare. MDMA use in the United States As of 2023, around **** million people in the United States had used MDMA at some point in their lifetime. Furthermore, around *** thousand people reported using MDMA in the past month. Although MDMA gained popularity as a club drug, it is now used by a wider range of people for different reasons. However, it’s use among high school students is still relatively rare. As of 2023, only *** percent of U.S. students in grades 8, 10, and 12 reported that they had used MDMA in their lifetime. In comparison, around **** percent of students said they had used marijuana in their lifetime. MDMA as therapy In recent years there has been increased interest in using psychedelic drugs such as MDMA, LSD, and psilocybin to treat mental disorders. The use of these substances for mental health treatment is known as psychedelic therapy. Clinical trials are now being run to investigate the use of MDMA to treat post-traumatic stress disorder (PTSD), depression, anxiety, and alcohol use disorder. From 2000 to 2022, there were ** clinical trials worldwide in phase two involving MDMA to treat PTSD.

The global vaporizer market is experiencing robust growth, driven by increasing acceptance of vaping for both recreational and therapeutic purposes. While precise market size figures for 2025 are unavailable, considering a conservative estimate based on industry trends and reported CAGRs for similar markets, we can project a 2025 market value of approximately $5 billion. This signifies a considerable expansion from the historical period (2019-2024), fueled by several key factors. The rising prevalence of chronic respiratory illnesses and the increasing availability of medical cannabis are significant contributors. Furthermore, technological advancements leading to safer and more efficient vaporizer designs, along with the growing popularity of e-cigarettes and discreet vaping devices, are driving market expansion. The market is segmented by type (e-cigarette vaporizers, marijuana vaporizers, medical vaporizers) and application (personal use, medical application, others), with e-cigarette vaporizers currently holding the largest market share. However, the medical and marijuana vaporizer segments are predicted to exhibit the highest growth rates, driven by expanding legalization and acceptance of cannabis for medicinal use. Regional analysis indicates strong market presence in North America and Europe, with Asia-Pacific expected to witness significant growth in the coming years due to increasing disposable incomes and changing consumer preferences. Sustained growth in the vaporizer market is anticipated throughout the forecast period (2025-2033). Assuming a moderate Compound Annual Growth Rate (CAGR) of 8%, the market is projected to reach a substantial size by 2033. This projected growth is tempered by existing regulatory challenges and public health concerns surrounding vaping. Government regulations regarding the sale and use of vaping products, along with ongoing research on the long-term health effects, represent potential restraints. However, the continuous innovation in product design, focusing on safety and efficiency, alongside the expansion of legal cannabis markets globally, will likely mitigate these challenges, ensuring the continued expansion of the vaporizer market. The competitive landscape is dynamic, with a mix of established players and emerging brands competing for market share.